Logo tissuegnostics

11.2020 - Tissue Cytometry with AI – Immunophenotyping and Quantifying the TME in-situ

CANCER RESEARCH UK (CRUK) - CAMBRIDGE CENTRE invited our CEO Rupert Ecker, TissueGnostics to give a talk about "Contextual Tissue Cytometry with AI - Immunophenotyping and Quantifying the Tumour Microenvironment".

10.2020 - Quantitative Tissue Cytometry - Immunophenotyping and AI-based Histomorphometry

At the Image Analysis Training School 2020, Nottingham Molecular Pathology Node, Dr Rupert Ecker presents the power of TissueGnostics' in situ Immunophenotyping and AI-based Histomorphometry analysis solutions.

08.2020 - Practical approaches for using tissue cytometry for clinical and research applications

In this webinar Dr. Kim RM Blenman, Yale School of Medicine, USA, presents her integration of TissueGnostics’ tissue cytometers and the contextual image cytometry software StrataQuest in a unique in-silico multiplexing workflow.

11.2020 - Advancing Tissue Cytometry - From Image to results

TG and De Novo Software started to collaborate by combining expertise in Image Cytometry. This webinar will teach researchers about the new streamlined workflow that enables scientists to quickly obtain publication-ready results from IF/IHC tissue sections.

09.2020 - TissueFAXS Cytometry - Enabeling Precision Medicine

Dr. Rupert Ecker, CEO of TissueGnostics, presents the TissueFAXS cytometry platform. TissueGnostics is a solution provider for Precision Medicine / Next-Generation Digital Pathology and produces fully integrated cutting-edge tissue cytometers.

Contact

TissueGnostics GmbH
Taborstraße 10/2/8
1020 Vienna, Austria
+43 1 216 11 90
This email address is being protected from spambots. You need JavaScript enabled to view it.

Please enable the javascript to submit this form

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies).
You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.